177 related articles for article (PubMed ID: 37824040)
1. Quantitative imaging of doxorubicin diffusion and cellular uptake in biomimetic gels with human liver tumor cells.
Degerstedt O; O'Callaghan P; Clavero AL; Gråsjö J; Eriksson O; Sjögren E; Hansson P; Heindryckx F; Kreuger J; Lennernäs H
Drug Deliv Transl Res; 2024 Apr; 14(4):970-983. PubMed ID: 37824040
[TBL] [Abstract][Full Text] [Related]
2. Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue.
Degerstedt O; Gråsjö J; Norberg A; Sjögren E; Hansson P; Lennernäs H
Eur J Pharm Sci; 2022 May; 172():106150. PubMed ID: 35231602
[TBL] [Abstract][Full Text] [Related]
3. A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties.
Calitz C; Pavlović N; Rosenquist J; Zagami C; Samanta A; Heindryckx F
J Vis Exp; 2020 Aug; (162):. PubMed ID: 32831309
[TBL] [Abstract][Full Text] [Related]
4. Influence of extracellular matrix composition on tumour cell behaviour in a biomimetic in vitro model for hepatocellular carcinoma.
Calitz C; Rosenquist J; Degerstedt O; Khaled J; Kopsida M; Fryknäs M; Lennernäs H; Samanta A; Heindryckx F
Sci Rep; 2023 Jan; 13(1):748. PubMed ID: 36639512
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma.
Kullenberg F; Degerstedt O; Calitz C; Pavlović N; Balgoma D; Gråsjö J; Sjögren E; Hedeland M; Heindryckx F; Lennernäs H
Cells; 2021 Jul; 10(7):. PubMed ID: 34359887
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
[TBL] [Abstract][Full Text] [Related]
7. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Qu J; Zhao X; Ma PX; Guo B
Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
[TBL] [Abstract][Full Text] [Related]
8. Examination of fabrication conditions of acrylate-based hydrogel formulations for doxorubicin release and efficacy test for hepatocellular carcinoma cell.
Bayramoglu G; Gozen D; Ersoy G; Ozalp VC; Akcali KC; Arica MY
J Biomater Sci Polym Ed; 2014; 25(7):657-78. PubMed ID: 24580096
[TBL] [Abstract][Full Text] [Related]
9. Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma.
Zhou X; Zhang M; Yung B; Li H; Zhou C; Lee LJ; Lee RJ
Int J Nanomedicine; 2012; 7():5465-74. PubMed ID: 23093902
[TBL] [Abstract][Full Text] [Related]
10. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.
Wang C; Wei X; Shao G
Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008
[TBL] [Abstract][Full Text] [Related]
11. An injectable thermosensitive hydrogel loaded with a theranostic nanoprobe for synergistic chemo-photothermal therapy for multidrug-resistant hepatocellular carcinoma.
Huang S; Ma Z; Sun C; Zhou Q; Li Z; Wang S; Yan Q; Liu C; Hou B; Zhang C
J Mater Chem B; 2022 Apr; 10(15):2828-2843. PubMed ID: 35316319
[TBL] [Abstract][Full Text] [Related]
12. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
[TBL] [Abstract][Full Text] [Related]
13. Homotypic Cell Membrane-Cloaked Biomimetic Nanocarrier for the Targeted Chemotherapy of Hepatocellular Carcinoma.
Liu X; Sun Y; Xu S; Gao X; Kong F; Xu K; Tang B
Theranostics; 2019; 9(20):5828-5838. PubMed ID: 31534522
[No Abstract] [Full Text] [Related]
14. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells.
Zheng SZ; Sun P; Wang JP; Liu Y; Gong W; Liu J
World J Gastroenterol; 2019 Jun; 25(22):2752-2762. PubMed ID: 31235998
[TBL] [Abstract][Full Text] [Related]
15. Cone-Beam Computed Tomography-Based Spatial Prediction of Drug Dose After Transarterial Chemoembolization Using Radiopaque Drug-Eluting Beads in Woodchuck Hepatocellular Carcinoma.
Mikhail AS; Pritchard WF; Negussie AH; Inkiyad G; Long DJ; Mauda-Havakuk M; Wakim PG; van der Sterren W; Levy EB; Lewis AL; Karanian JW; Wood BJ
Invest Radiol; 2022 Aug; 57(8):495-501. PubMed ID: 35239613
[TBL] [Abstract][Full Text] [Related]
16. Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells.
Pan YY; Xu SP; Jia XY; Xu HQ; Zhang Y; Rui LX; Wei W
Exp Oncol; 2007 Mar; 29(1):23-9. PubMed ID: 17431384
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MR diffusion-weighted imaging for monitoring the ultra-early treatment effect of sorafenib in human hepatocellular carcinoma xenografts.
Chen X; Ma Z; Huang Y; He L; Liang C; Shi C; Zhang Z; Liang C; Liu Z
J Magn Reson Imaging; 2017 Jul; 46(1):248-256. PubMed ID: 27783444
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.
Li J; Zhou M; Liu F; Xiong C; Wang W; Cao Q; Wen X; Robertson JD; Ji X; Wang YA; Gupta S; Li C
Radiology; 2016 Nov; 281(2):427-435. PubMed ID: 27347765
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-loaded Fe
Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
[TBL] [Abstract][Full Text] [Related]
20. Transferrin targeted core-shell nanomedicine for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinoma.
Malarvizhi GL; Retnakumari AP; Nair S; Koyakutty M
Nanomedicine; 2014 Nov; 10(8):1649-59. PubMed ID: 24905399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
